TARS · Tarsus Pharmaceuticals, Inc.

$58.02 -0.92 (-1.55%)

Market Cap

$2.52B

43.02M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Bobak Azamian	CEO	$726,333	—	$2,648,284	$2,651,487	$555,700	$36,175	$6,617,979
Jeffrey S. Farrow	CFO	$541,667	—	$893,961	$895,011	$264,900	$82,078	$2,677,617
Seshadri Neervannan	COO	$547,000	—	$893,961	$895,011	$267,300	$24,900	$2,628,172
Bryan Wahl	General Counsel and Secretary	$500,833	—	$893,961	$895,011	$245,500	$24,900	$2,560,205

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Bobak Azamian	CEO	$673,400	—	$3,370,153	$3,267,692	$532,800	$52,147	$7,896,192
Jeffrey S. Farrow	CFO	$520,833	—	$1,168,959	$1,133,398	$307,200	$102,536	$3,232,926
Seshadri Neervannan	COO	$527,333	—	$1,168,959	$1,133,398	$311,300	$53,699	$3,194,689
Aziz Mottiwala	Chief Commercial Officer	$492,633	—	$1,168,959	$1,133,398	$292,500	$51,372	$3,138,862
Elizabeth Yeu-Lin	Chief Medical Officer	$78,182	$25,000	$1,399,928	$1,548,238	—	$53,509	$3,104,857

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Jeffrey S. Farrow	CFO	$343,751	$100,000	$1,678,310	$1,590,572	$241,200	$37,997	$3,991,830
Bobak Azamian	CEO	$619,500	—	$1,029,364	$1,017,968	$450,300	$13,200	$3,130,332
Leonard Greenstein	CFO	$202,100	—	$411,746	$893,298	$71,552	$399,883	$1,978,579
Seshadri Neervannan	COO	$500,000	—	$494,095	$488,623	$246,000	$13,200	$1,741,918

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Bobak Azamian	CEO	$590,000	—	$876,822	$2,077,378	$324,500	$47,580	$3,916,280
Jose Trevejo	Chief Medical Officer	$403,333	$150,000	$606,054	$1,642,347	$176,000	$40,057	$3,017,791
Bryan Wahl	General Counsel	$420,000	—	$1,034,621	$880,641	$168,000	$31,087	$2,534,349

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Bobak Azamian	CEO	$550,000	—	—	$6,029,589	$269,500	$21,634	$6,870,723
Dianne Whitfield	Chief Human Resources Officer	$358,636	$194,599	—	$2,628,804	—	$25,665	$3,207,704
Bryan Wahl	General Counsel	$345,000	$50,000	—	$2,081,421	$141,408	$9,113	$2,626,942

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Bobak Azamian	CEO	$437,000	$211,484	—	$1,847,092	—	$14,820	$2,510,396
Seshadri Neervannan	COO	$199,621	$85,248	—	$1,926,633	—	$2,175	$2,213,677
Leo M. Greenstein	CFO	$256,023	$147,437	—	$418,703	—	$13,280	$835,443

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Bobak Azamian	CEO	$300,000	$116,137	—	—	—	—	$416,137

Executive changes

Person	Role	Change	Effective	Filed
David E.I. Pyott	Class III director	Appointed	2026-02-18	2026-02-18

Key facts CIK 1819790 CUSIP 87650L103 13F (30d) 32 filings 32 filers Visit website Investor relations